Company profile
UK company 08473331, incorporated on 4 April 2013.
Home | Talisman Therapeutics
Talisman Therapeutics Limited is a UK company with status active founded in 2013 based in East of England.
Company number 08473331
Financial period: 1 May 2024 to 30 Apr 2025
Reference milestones and recent Companies House filing stream events.
MA | Transaction MzU0NTY4NjIyNWFkaXF6a2N4 | Paper/PDF filed
Published 29 Sep 2026 23:15
SH01 | Transaction MzU0NTY4NDU0N2FkaXF6a2N4
Published 18 Sep 2026 14:31
AA | Transaction MzU0MjM4Njk4MWFkaXF6a2N4
Published 03 Sep 2026 13:19
Company registered at Companies House
Talisman Therapeutics is a human stem cell drug discovery company, based in Cambridge UK. We are committed to revolutionising the discovery of treatments for Alzheimer's disease (AD).
Currently have multiple collaborations with large pharma.
1 Jul 2018 to 31 Mar 2019
"Alzheimer's disease is becoming ever more prevalent and there remains very significant unmet medical need. Currently, there are no disease-modifying therapies. High profile clinical trial failures of potential Alzheimer's therapies have led scientists to seek alternative therapeutic strategies and to question the suitability of existing research models (...
